R. Aranda

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

Michael Schiff, M. Keiserman, C. Codding et al. · Annals of the Rheumatic Diseases · 2007 · 542 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease‐modifying antirheumatic drugs: A one‐year randomized, placebo‐controlled study

Michael E. Weinblatt, Bernard Combe, A. Covucci et al. · Arthritis & Rheumatism · 2006 · 383 citations · Full text

Medicine, Internal Medicine, Clinical Pharmacology +6

Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients

R. Aranda, Beate C. Sydora, P L McAllister et al. · The Journal of Immunology · 1997 · 318 citations

Life Sciences, Immunology, Pathology +17

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy

Mark C. Genovese, M. Schiff, Michael E. Luggen et al. · Annals of the Rheumatic Diseases · 2007 · 268 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

M. C. Genovese, A. Covarrubias, G. Léon et al. · Arthritis & Rheumatism · 2011 · 195 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14